ArticlePloS one2025
Hormonal contraceptives and body composition by use of stable isotope dilution techniques among women of reproductive age in Nyeri County, Kenya.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHormonal contraceptives are widely used by women of reproductive age (WRA) globally, yet their impact on body composition remains poorly understood, particularly in low-resource settings. This study aimed to assess the effects of hormonal contraceptives on body composition among WRA in Nyeri County, Kenya, using Stable Isotope Dilution Techniques (SIDT).
methodsA two-stage cross-sectional analytical study was conducted among 119 women of reproductive age (WRA) aged 18-49 years. However, five participants were excluded from the final analysis. Participants were purposively grouped into hormonal contraceptive users (n = 41), non-hormonal contraceptive users (n = 37), and not on contraceptive (n = 36). After accounting for loss to follow-up, 114 were analysed at baseline and 104 at endline. Contraceptive types included injectables (DMPA), oral pills, and implants (hormonal); and copper IUDs and condoms (non-hormonal). A mid-point (3-month) assessment was conducted for compliance, with the primary body composition outcome measured at six months. Demographic and socioeconomic data were collected using validated structured questionnaires. Body composition was assessed at baseline and six months later using SIDT, with saliva samples analysed to determine total body water (TBW), fat-free mass (FFM), and fat mass (FM). Physical activity (GPAQ) and dietary diversity (WDDS) were measured to control for confounding factors. Logistic regression analysis was adjusted for physical activity, and dietary diversity.
resultsHormonal contraceptive users showed a significant increase in body fat percentage from 35.3 ± 9.3% to 41.7 ± 10.6% (p = 0.039) and a reduction in %TBW (47.4 ± 6.8% to 42.3 ± 7.8%, p = 0.048). Non-hormonal and non-contraceptive users showed no significant changes. Regression analysis confirmed hormonal contraceptive use was a significant predictor of body fat percentage (Exp(β) = 0.31, p = 0.026), independent of other factors.
conclusionHormonal contraceptive use is associated with increased body fat and reduced total body water among WRA in Nyeri County. These changes, independent of physical activity and diet, suggest a direct metabolic effect. Regular body composition monitoring and tailored nutritional guidance are recommended for women using hormonal contraceptives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.